BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15193284)

  • 1. ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agent.
    Woessmann W; Zwanzger D; Borkhardt A
    Cell Biol Int; 2004; 28(5):403-10. PubMed ID: 15193284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ERK activation in growth and erythroid differentiation of K562 cells.
    Woessmann W; Mivechi NF
    Exp Cell Res; 2001 Apr; 264(2):193-200. PubMed ID: 11262176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of G proteins and ERK activation in hemin-induced erythroid differentiation of K562 cells.
    Kucukkaya B; Arslan DO; Kan B
    Life Sci; 2006 Feb; 78(11):1217-24. PubMed ID: 16216279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
    Eriksson M; Taskinen M; Leppä S
    J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells.
    Kohmura K; Miyakawa Y; Kawai Y; Ikeda Y; Kizaki M
    J Cell Physiol; 2004 Mar; 198(3):370-6. PubMed ID: 14755542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK.
    Huang HM; Chiou HY; Chang JL
    J Cell Biochem; 2006 Jul; 98(4):789-97. PubMed ID: 16440334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.
    Moosavi MA; Yazdanparast R; Lotfi A
    Int J Biochem Cell Biol; 2007; 39(9):1685-97. PubMed ID: 17543571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of Bcr-Abl function leads to erythroid differentiation of K562 cells via downregulation of ERK.
    Brózik A; Casey NP; Hegedus C; Bors A; Kozma A; Andrikovics H; Geiszt M; Német K; Magócsi M
    Ann N Y Acad Sci; 2006 Dec; 1090():344-54. PubMed ID: 17384279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AP-1 regulates alpha2beta1 integrin expression by ERK-dependent signals during megakaryocytic differentiation of K562 cells.
    Eriksson M; Arminen L; Karjalainen-Lindsberg ML; Leppä S
    Exp Cell Res; 2005 Mar; 304(1):175-86. PubMed ID: 15707584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JNK and ERK mitogen-activated protein kinases mediate THDA-induced apoptosis in K562 cells.
    Yang SH; Wu ZZ; Chien CM; Lo YH; Wu MJ; Chang LS; Lin SR
    Cell Biol Toxicol; 2008 Aug; 24(4):291-302. PubMed ID: 17934787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of glutamine enhances sodium butyrate-induced erythroid differentiation of K562 cells.
    Canh Hiep N; Kinohira S; Furuyama K; Taketani S
    J Biochem; 2012 Dec; 152(6):509-19. PubMed ID: 22923740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A G protein-associated ERK pathway is involved in LPS-induced proliferation and a PTK-associated p38 MAPK pathway is involved in LPS-induced differentiation in resting B cells.
    Kim J; Yang HY; Jang YS
    Mol Immunol; 2006 Mar; 43(8):1232-42. PubMed ID: 16098594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity.
    Kim M; Yan Y; Kortum RL; Stoeger SM; Sgagias MK; Lee K; Lewis RE; Cowan KH
    Cancer Res; 2005 May; 65(10):3986-92. PubMed ID: 15899786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL; Wu RT
    Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen peroxide-induced extracellular signal-regulated kinase activation in cultured feline ileal smooth muscle cells.
    Song HJ; Lee TS; Jeong JH; Min YS; Shin CY; Sohn UD
    J Pharmacol Exp Ther; 2005 Jan; 312(1):391-8. PubMed ID: 15328380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway.
    Li LB; Goleva E; Hall CF; Ou LS; Leung DY
    J Allergy Clin Immunol; 2004 Nov; 114(5):1059-69. PubMed ID: 15536411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways.
    Witt O; Sand K; Pekrun A
    Blood; 2000 Apr; 95(7):2391-6. PubMed ID: 10733512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanin delays apoptosis in K562 cells by downregulation of P38 MAP kinase.
    Wang D; Li H; Yuan H; Zheng M; Bai C; Chen L; Pei X
    Apoptosis; 2005 Oct; 10(5):963-71. PubMed ID: 16151632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells.
    Vintman L; Nielsen S; Berner A; Reich R; Davidson B
    Cancer; 2005 Jun; 103(11):2427-33. PubMed ID: 15830375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.